午夜视频在线播放,久久久无码精品亚洲A片消消乐

国产一级婬片A片免费无成人黑豆,亚洲AV无码乱码精品,黄色网址免费在线观看,少妇高潮久久久久久潘金莲

<noscript id="ccccc"><optgroup id="ccccc"></optgroup></noscript>

CN

CN EN

Latest News

Latest News Media Downloads Video Center

Kexing Biopharm's clinical trial application accepted for human interferon α1b inhalation solution
2022-08-19

2022-08-19

On the evening of August 18, 2022, Kexing Biopharm...
Kexing Biopharm's clinical trial application accepted for another dosage form of human interferon α2b
2022-08-15

2022-08-15

On the evening of August 14, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had recently received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Human Interferon α2b Spray" was accepted.
Kexing Biopharm's clinical trial application accepted for "Pegylated Human Granulocyte Colony-stimulating Factor Injection"
2022-08-02

2022-08-02

On the evening of August 1, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had just received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Pegylated Human Granulocyte Colony-stimulating Factor Injection" was accepted.
Kexing Biopharm's conference for reviewing operation and management in first half of 2022and planning key tasks for the second half-year held successfully
2022-08-01

2022-08-01

In the face of the complicated political and economic environment in China and overseas as well as the tough situation in the pharmaceutical industry, Kexing Biopharm proposed the working policy themed as "intensely licensing in new products, firmly promoting R&D and innovation, and proactively creating business in new industries" at the beginning of the year, and continuously followed and implemented the policy in the first half-year.
Phase I clinical trial kick-off meeting of Kexing Biopharm's COVID-19 oral drug SHEN26 Capsule held successfully
2022-07-22

2022-07-22

On July 20, 2022, the phase I clinical trial kick-off meeting of SHEN26 Capsule, a small-molecule oral drug against COVID-19 jointly developed by Shenzhen Kexing Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kexing Biopharm (688136.SH), and Shenzhen Antiv Pharma Co., Ltd., was successfully held in the Second Affiliated Hospital of Anhui Medical University, indicating the official start of the clinical study for the project.

1 2 3 4 5

Support Hotline

0755-26546500
Online Consultation
QR Code

Scan Code Consultation

欧美精品二三四区人妻斩 | 天天躁日日躁狠狠躁欧美老妇小说 | 白丝女仆被免费视频网站 | 久久无码网站 - 百度 | 苍井そら无码流出IPZ-440 | 色诱大奶少妇在线看 | 午夜无码精品一区二区三区99午 | 国产精品视频在线观看 | jeppesen五十路亂倫 | 国产二区色凤鸣阁 | …免费看`美女黄色视频 | 甘肃WBBBB搡wBBBB | 野外卖婬片A片免费视频 | 无码人妻精品一区二区蜜桃91 | 在线观看强奸美女视频网站大全 | 国产一级a毛一级a看免费软件特色 | 国产日本美国在线视频观看视频 | 无码人妻精品一区二区二秋霞影院 | 欧美性潮喷XXXXX免费视频看 | 中国一级片免费在线播放 | 国模精品无码一区二区免费蜜桃 | 国产乱人偷精品人妻A片免费网址 | 在线无码观看免费网站入口 | 毛片在线免费观看视频 | 丰满爆乳一区二区三区霸乳 | 国产拍在线观看不卡 | 裸体美女永久免费无遮挡 | 日韩精品一区二区在线 | 国产婬乱A片无码区亚洲成a人 | 人妻熟妇国产乱码精品精 | 免费做a爰片久久毛片A片 | 国产精品海角社区免费播放 | 日韩一曲二曲三曲电影 | 亚洲日韩字幕在线一区二区 | 亚洲无码软件导航影音先锋 | 深夜催精毛片久久久久久 | 国产精品久久久久久无码人妻 | 久久99久久99精品蜜柚传媒 | 色屁屁XXXXⅩ在线视频 | 国产精品无码粉嫩小泬 | 午夜剧场三级爱爱黑人 |

<nav id="c0cc0"><code id="c0cc0"></code></nav>

<noscript id="c0cc0"></noscript>